Visión generalGráficoNoticiasTraderScreen

Morgan Stanley Call 42 FRE 20.09..../  DE000ME10YX3  /

Stuttgart
14/05/2024  11:23:36 Diferencia0.000 Bid13:05:34 Ask13:05:34 Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
0.010EUR 0.00% 0.011
Volumen de oferta: 250,000		 0.040
Tamaño/ Volumen/ Formato de Ask: 250,000		 FRESENIUS SE+CO.KGAA... 42.00 - 20/09/2024 Call
GlobeNewswire 13:35 Avicanna Reports Q1 2024 and First Positive Adjusted EBIDTA Quarter
TeleTrader 13:32 GameStop skyrockets 120% as meme stock rally goes on
TeleTrader 13:30 China outraged over higher US tariffs
GlobeNewswire 13:30 Kroma Announces Spectrum’s Launch Alongside Expansion Plans
GlobeNewswire 13:30 Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire 13:30 MiNK Reports First Quarter 2024 Results
GlobeNewswire 13:30 Alimera Sciences Reports First Quarter 2024 Results
GlobeNewswire 13:30 Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enable...
GlobeNewswire 13:30 ETFS Capital Calls on WisdomTree to Stop Fighting Stockholders and Run a Strategic Process
GlobeNewswire 13:30 Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Tr...
GlobeNewswire 13:30 Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire 13:30 Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
GlobeNewswire 13:30 Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
GlobeNewswire 13:30 FitLife Brands Announces First Quarter 2024 Results
GlobeNewswire 13:30 BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 20...
GlobeNewswire 13:30 Batteh Named Saia’s Chief Financial Officer
GlobeNewswire 13:30 XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
GlobeNewswire 13:30 Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire 13:30 Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ
GlobeNewswire 13:30 HealthEquity Closes Acquisition of BenefitWallet HSA Portfolio
GlobeNewswire 13:30 Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results
GlobeNewswire 13:30 Tavros Therapeutics Achieves Two Milestone Payments in its Collaboration with Vividion Therapeutics
GlobeNewswire 13:30 nCino Announces Timing of its First Quarter Fiscal Year 2025 Financial Results Conference Call
GlobeNewswire 13:30 2024 Rabbet Report: Risk Management and Automation Emerge as Top Priorities in Construction Finance
GlobeNewswire 13:30 Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise